In this report it is shown that intravenous formulation of isavuconazole could be administered 5/7 days a week in patients who can not swallow capsules, once the steady state has been stably reached and maintained, thanks to its very long half-life. In this case TDM should be highly recommended.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/1120009X.2020.1755591 | DOI Listing |
Publication Analysis
Top Keywords
isavuconazole administered
8
intravenous isavuconazole
4
administered days-a-week
4
days-a-week possibility
4
possibility suggested
4
suggested real-life
4
real-life observation
4
observation report
4
report intravenous
4
intravenous formulation
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!